170 related articles for article (PubMed ID: 25192509)
1. The leukodystrophies.
Gordon HB; Letsou A; Bonkowsky JL
Semin Neurol; 2014 Jul; 34(3):312-20. PubMed ID: 25192509
[TBL] [Abstract][Full Text] [Related]
2. Leukodystrophies in Children: Diagnosis, Care, and Treatment.
Bonkowsky JL; Keller S;
Pediatrics; 2021 Sep; 148(3):. PubMed ID: 34426533
[TBL] [Abstract][Full Text] [Related]
3. Estimating the relative frequency of leukodystrophies and recommendations for carrier screening in the era of next-generation sequencing.
Schmidt JL; Pizzino A; Nicholl J; Foley A; Wang Y; Rosenfeld JA; Mighion L; Bean L; da Silva C; Cho MT; Truty R; Garcia J; Speare V; Blanco K; Powis Z; Hobson GM; Kirwin S; Krock B; Lee H; Deignan JL; Westemeyer MA; Subaran RL; Thiffault I; Tsai EA; Fang T; Helman G; Vanderver A
Am J Med Genet A; 2020 Aug; 182(8):1906-1912. PubMed ID: 32573057
[TBL] [Abstract][Full Text] [Related]
4. Hypomyelinating leukodystrophies - a molecular insight into the white matter pathology.
Charzewska A; Wierzba J; Iżycka-Świeszewska E; Bekiesińska-Figatowska M; Jurek M; Gintowt A; Kłosowska A; Bal J; Hoffman-Zacharska D
Clin Genet; 2016 Oct; 90(4):293-304. PubMed ID: 27234264
[TBL] [Abstract][Full Text] [Related]
5. Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher-like disease 1, and related hypomyelinating disorders.
Hobson GM; Garbern JY
Semin Neurol; 2012 Feb; 32(1):62-7. PubMed ID: 22422208
[TBL] [Abstract][Full Text] [Related]
6. [Congenital hypomyelinating leukodystrophies--from genomic dissection to molecular diagnosis and potential therapies].
Inoue K; Iwaki A; Kurosawa K; Takanashi J; Deguchi K; Yamamoto T; Osaka H
No To Hattatsu; 2013 Mar; 45(2):122-6. PubMed ID: 23650816
[No Abstract] [Full Text] [Related]
7. Pelizaeus-Merzbacher-Like disease presentation of MCT8 mutated male subjects.
Vaurs-Barrière C; Deville M; Sarret C; Giraud G; Des Portes V; Prats-Viñas JM; De Michele G; Dan B; Brady AF; Boespflug-Tanguy O; Touraine R
Ann Neurol; 2009 Jan; 65(1):114-8. PubMed ID: 19194886
[TBL] [Abstract][Full Text] [Related]
8. Stem cell-based strategies for treating pediatric disorders of myelin.
Goldman SA; Schanz S; Windrem MS
Hum Mol Genet; 2008 Apr; 17(R1):R76-83. PubMed ID: 18632701
[TBL] [Abstract][Full Text] [Related]
9. A brief history of Pelizaeus-Merzbacher disease and proteolipid protein.
Koeppen AH
J Neurol Sci; 2005 Feb; 228(2):198-200. PubMed ID: 15694205
[No Abstract] [Full Text] [Related]
10. Lysosomal Leukodystrophies Lysosomal Storage Diseases Associated With White Matter Abnormalities.
Maegawa GHB
J Child Neurol; 2019 May; 34(6):339-358. PubMed ID: 30757954
[TBL] [Abstract][Full Text] [Related]
11. Pelizaeus-Merzbacher disease: pathogenic mechanisms and insights into the roles of proteolipid protein 1 in the nervous system.
Garbern JY
J Neurol Sci; 2005 Feb; 228(2):201-3. PubMed ID: 15694206
[No Abstract] [Full Text] [Related]
12. Advances and pitfalls of cell therapy in metabolic leukodystrophies.
Miranda CO; Brites P; Mendes Sousa M; Teixeira CA
Cell Transplant; 2013; 22(2):189-204. PubMed ID: 23006656
[TBL] [Abstract][Full Text] [Related]
13. The burden of inherited leukodystrophies in children.
Bonkowsky JL; Nelson C; Kingston JL; Filloux FM; Mundorff MB; Srivastava R
Neurology; 2010 Aug; 75(8):718-25. PubMed ID: 20660364
[TBL] [Abstract][Full Text] [Related]
14. Myelin mishaps.
Barkovich AJ
Ann Neurol; 2007 Aug; 62(2):107-9. PubMed ID: 17683086
[No Abstract] [Full Text] [Related]
15. Variable expression of a novel PLP1 mutation in members of a family with Pelizaeus-Merzbacher disease.
Fattal-Valevski A; DiMaio MS; Hisama FM; Hobson GM; Davis-Williams A; Garbern JY; Mahoney MJ; Kolodny EH; Pastores GM
J Child Neurol; 2009 May; 24(5):618-24. PubMed ID: 19151366
[TBL] [Abstract][Full Text] [Related]
16. Pelizaeus-Merzbacher Disease: A Caregiver Assessment of Disease Impact.
Moore KM; Wolf NI; Hobson G; Bowyer K; McSherry J; Hartin G; Wilde C; Shapiro S; Frank J; Manley D; Junge C
J Child Neurol; 2023 Feb; 38(1-2):78-84. PubMed ID: 36744386
[TBL] [Abstract][Full Text] [Related]
17. PLP/DM20 expression and turnover in a transgenic mouse model of Pelizaeus-Merzbacher disease.
Karim SA; Barrie JA; McCulloch MC; Montague P; Edgar JM; Iden DL; Anderson TJ; Nave KA; Griffiths IR; McLaughlin M
Glia; 2010 Nov; 58(14):1727-38. PubMed ID: 20629189
[TBL] [Abstract][Full Text] [Related]
18. Molecular triggers of neuroinflammation in mouse models of demyelinating diseases.
Barrette B; Nave KA; Edgar JM
Biol Chem; 2013 Dec; 394(12):1571-81. PubMed ID: 23959664
[TBL] [Abstract][Full Text] [Related]
19. Clinical, radiological and genetic aspects of leukodystrophies.
László A; Elpeleg O; Horváth K; Jakobs C; Kóbor J; Gal A; Barsi P; Kelemen A; Saracz J; Svékus A; Tegzes A; Vörös E
Ideggyogy Sz; 2010 Jul; 63(7-8):266-73. PubMed ID: 20812455
[TBL] [Abstract][Full Text] [Related]
20. Umbilical cord blood transplantation to treat Pelizaeus-Merzbacher Disease in 2 young boys.
Wishnew J; Page K; Wood S; Galvin L; Provenzale J; Escolar M; Gustafson K; Kurtzberg J
Pediatrics; 2014 Nov; 134(5):e1451-7. PubMed ID: 25287453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
